Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk. Daghlas I, Georgakis MK, Brennan SO, Arsenault BJ, et al. Atherosclerosis 2026;415:120723.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Daghlas I, Georgakis MK, Brennan SO, Arsenault BJ, et al. Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk. Atherosclerosis 2026;415:120723.
PMID: 41932221